Molnupiravir capsules . Photo : AFP Photo / Merck and Co , Inc
New COVID treatment
Vulnerable Australians first in line for new COVID-19 pill .
Aged care residents , people who are unvaccinated and other at-risk communities will be among the first in the country to receive a newly approved at-home COVID-19 treatment .
Antiviral pill Lagevrio , also known as molnupiravir , was recently listed on the Pharmaceutical Benefits Scheme .
Under the guidelines , doctors will be able to prescribe the drug to eligible adults with high risk factors , including age , other medical conditions or being moderately or severely immunocompromised .
It also must be prescribed within five days of symptom onset following a positive PCR or RAT test result .
It ’ s expected the oral treatment will cost just $ 6.80 for concession card holders or $ 42.50 for general patients .
But the treatment will not be made immediately available to the wider population .
Chief medical officer Paul Kelly previously outlined the nation ’ s most vulnerable communities would be the first to receive the pill .
“ Once the treatments do start to come into the country , the Australian government will be working closely with the state and territory governments to ensure these treatments get distributed to those people who are most at risk ,” he said in January .
“ This , in the first instance , is likely to include people infected in outbreaks in remote Aboriginal and Torres Strait Islander communities and those infected in outbreaks in residential aged care and disability care settings .
“ Then , over coming months , as supply increases , we may see more wide distribution available across the population .” Lagevrio was approved by the nation ’ s medical regulator for use in January along with Pfizer ’ s oral treatment Paxlovid .
Both drugs are aimed at reducing hospitalisation of mild and moderate illnesses and will be welcomed by many in remote and rural communities without access to a hospital . ■
Practice Health Check
An online assessment tool helping residential aged care homes assess the dementia knowledge , skills and attitudes among staff .
Dementia Practice Health Check :
• Assists your organisation in meeting the Aged Care Quality Standards and consumer expectations .
• Identifies knowledge gaps and prioritises areas for staff development .
• Helps to demonstrate internal improvement and measure performance against other organisations .
To find out more and complete your first free assessment visit : dementialearning . org . au / practice-health-check
nursingreview . com . au | 5